Clinomics Inc. (KOSDAQ: 352770)

Clinomics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 18, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	20,031	82,006	88,076	170,350	225,541	-
Market Cap Growth	-64.88%	-6.89%	-48.30%	-24.47%	-	-
Enterprise Value	48,913	81,246	82,753	137,341	217,505	-
Last Close Price	521.00	2565.00	3619.29	7080.02	9485.59	-
PE Ratio	-	-	-	10.75	-	-
PS Ratio	2.14	7.19	3.82	3.07	22.97	-
PB Ratio	0.54	1.91	1.56	2.91	5.65	-
P/TBV Ratio	0.87	2.51	1.69	2.94	5.70	-
P/OCF Ratio	-	-	-	80.43	-	-
EV/Sales Ratio	5.93	7.12	3.58	2.48	22.15	-
EV/EBITDA Ratio	-	-	-	5.37	-	-
EV/EBIT Ratio	-	-	-	5.99	-	-
Debt / Equity Ratio	0.85	0.47	0.36	0.29	0.02	3.81
Debt / EBITDA Ratio	-	-	-	0.66	-	-
Asset Turnover	0.08	0.13	0.23	0.76	0.28	0.24
Inventory Turnover	3.35	4.43	6.78	15.86	10.76	5.90
Quick Ratio	0.09	0.71	1.42	1.82	12.54	8.35
Current Ratio	0.32	0.89	1.55	1.90	13.12	9.03
Return on Equity (ROE)	-68.55%	-85.44%	-17.81%	32.18%	-58.47%	-120.54%
Return on Assets (ROA)	-17.37%	-25.20%	-6.78%	19.58%	-21.68%	-16.38%
Return on Capital (ROIC)	-22.02%	-30.96%	-8.90%	24.67%	-23.56%	-18.58%
Earnings Yield	-194.42%	-51.53%	-11.55%	9.31%	-5.83%	-
FCF Yield	-78.73%	-14.94%	-22.37%	-1.98%	-5.44%	-
Buyback Yield / Dilution	-35.71%	-13.00%	-10.94%	-42.15%	-18.35%	-22.24%
Total Shareholder Return	-35.71%	-13.00%	-10.94%	-42.15%	-18.35%	-22.24%

Source: S&P Capital IQ. Standard template. Financial Sources.